ATE216236T1 - Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung - Google Patents

Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung

Info

Publication number
ATE216236T1
ATE216236T1 AT95907963T AT95907963T ATE216236T1 AT E216236 T1 ATE216236 T1 AT E216236T1 AT 95907963 T AT95907963 T AT 95907963T AT 95907963 T AT95907963 T AT 95907963T AT E216236 T1 ATE216236 T1 AT E216236T1
Authority
AT
Austria
Prior art keywords
metronidazole
aqueous
methods
aqueous soluble
compositions
Prior art date
Application number
AT95907963T
Other languages
English (en)
Inventor
Subhash Desai
Alan Mark Mancini
Steven Charles Schumann
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE216236T1 publication Critical patent/ATE216236T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT95907963T 1994-01-27 1995-01-04 Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung ATE216236T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/187,568 US6103262A (en) 1994-01-27 1994-01-27 Modified-release metronidazole compositions and methods for making and using same
PCT/US1995/000005 WO1995020383A1 (en) 1994-01-27 1995-01-04 Modified-release metronidazole compositions and methods for making and using same

Publications (1)

Publication Number Publication Date
ATE216236T1 true ATE216236T1 (de) 2002-05-15

Family

ID=22689500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907963T ATE216236T1 (de) 1994-01-27 1995-01-04 Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung

Country Status (16)

Country Link
US (2) US6103262A (de)
EP (1) EP0744947B1 (de)
JP (1) JPH09508381A (de)
KR (1) KR100368769B1 (de)
CN (1) CN1095665C (de)
AT (1) ATE216236T1 (de)
AU (1) AU682248B2 (de)
BR (1) BR9506662A (de)
CA (1) CA2181985C (de)
DE (1) DE69526434T2 (de)
DK (1) DK0744947T3 (de)
ES (1) ES2174930T3 (de)
MX (1) MX9602951A (de)
NZ (1) NZ279368A (de)
PT (1) PT744947E (de)
WO (1) WO1995020383A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004829A1 (en) 1997-07-28 1999-02-04 Redmond Mary L Composition and process for the treatment of epidermal traumas such as decubitus ulcers
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
ECSP003851A (es) * 1999-12-22 2002-05-23 Pharmacia Corp Composicon de liberacion doble de un inhibidor ciclooxigenasa-2
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
US8846100B2 (en) 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
US20130259947A1 (en) 2010-11-29 2013-10-03 Dr. Reddy's Laboratories Ltd. Oral metronidazole pharmaceutical compositions
US20140377347A1 (en) * 2012-01-23 2014-12-25 Ranbaxy Laboratories Limited In-situ multilayered tablet technology
AU2015311674B2 (en) 2014-09-05 2018-03-08 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
CA2988082C (en) * 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2017027528A1 (en) * 2015-08-10 2017-02-16 Purdue Research Foundation Methods and systems for depositing active ingredients on substrates
GR1008992B (el) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
CN112007002B (zh) * 2020-08-05 2022-08-12 河北君临药业有限公司 一种质量稳定的甲硝唑片剂组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944061A (en) * 1957-09-20 1960-07-05 Acyl derivatives and process
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
DE4125048A1 (de) * 1991-07-29 1993-02-04 Peggy Albrecht Arzneimittel mit verzoegerter freisetzung zur behandlung von periodontitis
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device

Also Published As

Publication number Publication date
AU1596795A (en) 1995-08-15
JPH09508381A (ja) 1997-08-26
DE69526434T2 (de) 2002-10-31
CN1095665C (zh) 2002-12-11
US5618559A (en) 1997-04-08
US6103262A (en) 2000-08-15
BR9506662A (pt) 1997-11-18
EP0744947A1 (de) 1996-12-04
CA2181985A1 (en) 1995-08-03
NZ279368A (en) 1998-04-27
MX9602951A (es) 1997-06-28
AU682248B2 (en) 1997-09-25
CA2181985C (en) 2000-12-05
WO1995020383A1 (en) 1995-08-03
ES2174930T3 (es) 2002-11-16
PT744947E (pt) 2002-08-30
KR100368769B1 (ko) 2003-05-16
EP0744947B1 (de) 2002-04-17
DE69526434D1 (de) 2002-05-23
CN1139382A (zh) 1997-01-01
DK0744947T3 (da) 2002-07-29

Similar Documents

Publication Publication Date Title
ATE216236T1 (de) Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung
NO962040D0 (no) Mikroinnkapslede 3-piperidinyl-substituerte 1,2-benzisoksazoler og 1,2-benzisotiazoler
DE69104991T2 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
HUP0400382A2 (hu) Késleltetett leadású készítmény és eljárás annak előállítására
MXPA04011914A (es) Formulacion farmaceutica de liberacion modificada.
HK1080764A1 (en) Implant for transport and release for pharmacologically active agents as well as a process for producing the same
DE69726457D1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
IL112020A0 (en) Arylacetic acid derivatives, their preparation and their use as fungicides
ATE164578T1 (de) Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten
MX9708696A (es) Cefalosporinas antibacterianas.
DE60002126D1 (de) Substituierte dimere Carboxamid-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
WO2002028821A3 (de) Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften.
DE69410614T2 (de) Bis-naphthalimide für die behandlung von krebs
FI954786A (fi) Menetelmä aminometaanifosfonihapon valmistamiseksi
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
WO2000007580A3 (en) Pharmaceutical compositions against autoimmune diseases
IT1273455B (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ATE145205T1 (de) Dithiansubstituierte propenale und verfahren zu ihrer herstellung
NO974197L (no) Fremgangsmåte til fremstilling av estere av anhydroecgonin
UA10118A (uk) Засіб для підвищення фізіологічної активності рослин пшениці в умовах посухи
ES2079997A1 (es) Compuestos de fenil fenol sustituidos antagonistas de leucotrieno, procedimiento para su obtencion y formulaciones farmaceuticas de los mismos.
EP0390066A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
SE9304065D0 (sv) New compound

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee